Hennion & Walsh Asset Management, Inc. Cogent Biosciences, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.06 Billion
- Q3 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 171,999 shares of COGT stock, worth $2.02 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
171,999
Previous 127,712
34.68%
Holding current value
$2.02 Million
Previous $1.08 Million
72.58%
% of portfolio
0.09%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding COGT
# of Institutions
162Shares Held
114MCall Options Held
104KPut Options Held
163K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct10.5MShares$123 Million0.24% of portfolio
-
Commodore Capital LP New York, NY9.74MShares$114 Million7.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.26MShares$109 Million6.08% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$85.4 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$81.6 Million8.79% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $771M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...